Article
Landscape Of Genetic Lesions In 944 Patients With Myelodysplastic Syndromes
2013-11-15
Abstract excerpt
Abstract Background Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid neoplasms characterized by varying degrees of cytopenias and a predisposition to acute myeloid leukemia (AML). With conspicuous clinical and biological heterogeneity in MDS, an optimized choice of treatment based on accurate diagnosis and risk stratification in individual patients is central to the current therapeutic strategy...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d0ef8bc4-d13a-552b-88e3-d61f9c948d8b
- DOI
- 10.1182/blood.v122.21.521.521
